Colussi, Claudia <br/><br/>
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Dec 2008 
 - 19183-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.0805514105  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzamides--pharmacology<br/>Cells, Cultured<br/>Enzyme Inhibitors--pharmacology<br/>Epigenesis, Genetic<br/>Histone Deacetylase 2<br/>Histone Deacetylase Inhibitors<br/>Histone Deacetylases--genetics<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Inbred mdx<br/>Muscle, Skeletal--cytology<br/>Muscular Dystrophy, Animal--drug therapy<br/>Muscular Dystrophy, Duchenne--drug therapy<br/>Myoblasts--cytology<br/>Nitric Oxide--metabolism<br/>Nitrogen--metabolism<br/>Pyridines--pharmacology<br/>RNA, Small Interfering<br/>Repressor Proteins--antagonists & inhibitors<br/>Satellite Cells, Skeletal Muscle--cytology